Eli Frydman Ph.D

Eli Frydman Ph.D General Information

Biography

Dr. Eli Frydman serves as Board Member at Carevature Medical. He served as Board Member at Beta-O2 Technologies. He served as Managing Director, Healthcare at Aurum Ventures MKI. He served as Board Member at PolyPid. He is a seasoned healthcare executive with diverse industry experience. Prior to Joining Aurum, he served as the Chief Business Officer of FutuRx, the drug development incubator established by J&J, Orbimed, and Takeda under a franchise from the Israeli Innovation Authority. In this position, he played a key role in establishing multiple new drug development startup companies based on sourcing and licensing breakthrough drug technologies in Israel and abroad. Prior to that, he served for 10 years as the COO of Aposense Ltd., a drug development and molecular imaging company (TASE: APOS), with responsibilities across business development, operations, and finance. Before joining Aposense, he served as a Senior Business Development Manager in GE Healthcare Europe (based in France), doing Healthcare M&A across Europe. He holds an MBA from the Ecole des Ponts, Paris, France, and a Ph.D. in Chemistry (nanotechnology) from the Weizmann Institute of Science. He served as Board Member at Nucleix.